 | • レポートコード：MRC2102QY11798 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医療機器 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の肺用ドラッグデリバリーデバイス/システム市場について種類別（定量吸入器、ドライパウダー吸入器、ネブライザー、アクセサリ）、用途別（病院・診療所、在宅医療）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・肺用ドラッグデリバリーデバイス/システム市場の概要 ・世界の主要地域別肺用ドラッグデリバリーデバイス/システム市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の肺用ドラッグデリバリーデバイス/システム市場規模2015-2026：種類別（定量吸入器、ドライパウダー吸入器、ネブライザー、アクセサリ） ・世界の肺用ドラッグデリバリーデバイス/システム市場規模2015-2026：用途別（病院・診療所、在宅医療） ・肺用ドラッグデリバリーデバイス/システムの米国市場規模2015-2020 ・肺用ドラッグデリバリーデバイス/システムのヨーロッパ市場規模2015-2020 ・肺用ドラッグデリバリーデバイス/システムの中国市場規模2015-2020 ・肺用ドラッグデリバリーデバイス/システムの日本市場規模2015-2020 ・肺用ドラッグデリバリーデバイス/システムの東南アジア市場規模2015-2020 ・肺用ドラッグデリバリーデバイス/システムのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・肺用ドラッグデリバリーデバイス/システムの製造コスト分析 ・販売チャネル、流通業者、顧客 ・肺用ドラッグデリバリーデバイス/システムの市場動向・機会・課題 ・調査の結論 |
Pulmonary Drug Delivery Devices/Systems include metered dose inhalers,dry powder inhalers,nebulizers and accessories.
North America dominates the dominant drug delivery devices/systems market position. Major local pharmaceutical and medical device manufacturers, advanced medical infrastructure, population ageing, high disposable income and lifestyle changes are all factors driving the overall growth of the North American pharmaceutical drug delivery devices/systems market.
Market Analysis and Insights: Global Pulmonary Drug Delivery Devices/Systems Market
The global Pulmonary Drug Delivery Devices/Systems market size is projected to reach US$ 3741.8 million by 2026, from US$ 2923.3 million in 2020, at a CAGR of 4.2% during 2021-2026.
Global Pulmonary Drug Delivery Devices/Systems Scope and Market Size
The global Pulmonary Drug Delivery Devices/Systems market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pulmonary Drug Delivery Devices/Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Pulmonary Drug Delivery Devices/Systems market is segmented into
Metered Dose Inhalers
Dry Powder Inhalers
Nebulizers
Accessories
Segment by Application, the Pulmonary Drug Delivery Devices/Systems market is segmented into
Hospitals and Clinics
Homecare
The Pulmonary Drug Delivery Devices/Systems market is analysed and market size information is provided by regions (countries). Segment by Application, the Pulmonary Drug Delivery Devices/Systems market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pulmonary Drug Delivery Devices/Systems Market Share Analysis
Pulmonary Drug Delivery Devices/Systems market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pulmonary Drug Delivery Devices/Systems business, the date to enter into the Pulmonary Drug Delivery Devices/Systems market, Pulmonary Drug Delivery Devices/Systems product introduction, recent developments, etc.
The major vendors covered:
Hovione
3M Health Care
Bespak
BeyonDevices
GlaxoSmithKline
H&T Presspart
PARI Respiratory Equipment
Philips Respironics
SHL
1 Pulmonary Drug Delivery Devices/Systems Market Overview
1.1 Pulmonary Drug Delivery Devices/Systems Product Scope
1.2 Pulmonary Drug Delivery Devices/Systems Segment by Type
1.2.1 Global Pulmonary Drug Delivery Devices/Systems Sales by Type (2020-2026)
1.2.2 Metered Dose Inhalers
1.2.3 Dry Powder Inhalers
1.2.4 Nebulizers
1.2.5 Accessories
1.3 Pulmonary Drug Delivery Devices/Systems Segment by Application
1.3.1 Global Pulmonary Drug Delivery Devices/Systems Sales Comparison by Application (2020-2026)
1.3.2 Hospitals and Clinics
1.3.3 Homecare
1.4 Pulmonary Drug Delivery Devices/Systems Market Estimates and Forecasts (2015-2026)
1.4.1 Global Pulmonary Drug Delivery Devices/Systems Sales Growth Rate (2015-2026)
1.4.2 Global Pulmonary Drug Delivery Devices/Systems Revenue and Growth Rate (2015-2026)
1.4.3 Global Pulmonary Drug Delivery Devices/Systems Price Trends (2015-2026)
2 Pulmonary Drug Delivery Devices/Systems Estimate and Forecast by Region
2.1 Global Pulmonary Drug Delivery Devices/Systems Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Pulmonary Drug Delivery Devices/Systems Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Region (2015-2020)
2.2.2 Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Region (2015-2020)
2.3 Global Pulmonary Drug Delivery Devices/Systems Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Pulmonary Drug Delivery Devices/Systems Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Pulmonary Drug Delivery Devices/Systems Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Pulmonary Drug Delivery Devices/Systems Estimates and Projections (2015-2026)
2.4.2 Europe Pulmonary Drug Delivery Devices/Systems Estimates and Projections (2015-2026)
2.4.3 China Pulmonary Drug Delivery Devices/Systems Estimates and Projections (2015-2026)
2.4.4 Japan Pulmonary Drug Delivery Devices/Systems Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Pulmonary Drug Delivery Devices/Systems Estimates and Projections (2015-2026)
2.4.6 India Pulmonary Drug Delivery Devices/Systems Estimates and Projections (2015-2026)
3 Global Pulmonary Drug Delivery Devices/Systems Competition Landscape by Players
3.1 Global Top Pulmonary Drug Delivery Devices/Systems Players by Sales (2015-2020)
3.2 Global Top Pulmonary Drug Delivery Devices/Systems Players by Revenue (2015-2020)
3.3 Global Pulmonary Drug Delivery Devices/Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary Drug Delivery Devices/Systems as of 2019)
3.4 Global Pulmonary Drug Delivery Devices/Systems Average Price by Company (2015-2020)
3.5 Manufacturers Pulmonary Drug Delivery Devices/Systems Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Pulmonary Drug Delivery Devices/Systems Players (Opinion Leaders)
4 Global Pulmonary Drug Delivery Devices/Systems Market Size by Type
4.1 Global Pulmonary Drug Delivery Devices/Systems Historic Market Review by Type (2015-2020)
4.1.1 Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2015-2020)
4.1.2 Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Type (2015-2020)
4.1.3 Global Pulmonary Drug Delivery Devices/Systems Price by Type (2015-2020)
4.2 Global Pulmonary Drug Delivery Devices/Systems Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Pulmonary Drug Delivery Devices/Systems Sales Forecast by Type (2021-2026)
4.2.2 Global Pulmonary Drug Delivery Devices/Systems Revenue Forecast by Type (2021-2026)
4.2.3 Global Pulmonary Drug Delivery Devices/Systems Price Forecast by Type (2021-2026)
5 Global Pulmonary Drug Delivery Devices/Systems Market Size by Application
5.1 Global Pulmonary Drug Delivery Devices/Systems Historic Market Review by Application (2015-2020)
5.1.1 Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2015-2020)
5.1.2 Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Application (2015-2020)
5.1.3 Global Pulmonary Drug Delivery Devices/Systems Price by Application (2015-2020)
5.2 Global Pulmonary Drug Delivery Devices/Systems Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Pulmonary Drug Delivery Devices/Systems Sales Forecast by Application (2021-2026)
5.2.2 Global Pulmonary Drug Delivery Devices/Systems Revenue Forecast by Application (2021-2026)
5.2.3 Global Pulmonary Drug Delivery Devices/Systems Price Forecast by Application (2021-2026)
6 United States Pulmonary Drug Delivery Devices/Systems Market Facts & Figures
6.1 United States Pulmonary Drug Delivery Devices/Systems Sales Market Share by Company (2015-2020)
6.2 United States Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2015-2020)
6.3 United States Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2015-2020)
7 Europe Pulmonary Drug Delivery Devices/Systems Market Facts & Figures
7.1 Europe Pulmonary Drug Delivery Devices/Systems Sales Market Share by Company (2015-2020)
7.2 Europe Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2015-2020)
7.3 Europe Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2015-2020)
8 China Pulmonary Drug Delivery Devices/Systems Market Facts & Figures
8.1 China Pulmonary Drug Delivery Devices/Systems Sales Market Share by Company (2015-2020)
8.2 China Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2015-2020)
8.3 China Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2015-2020)
9 Japan Pulmonary Drug Delivery Devices/Systems Market Facts & Figures
9.1 Japan Pulmonary Drug Delivery Devices/Systems Sales Market Share by Company (3015-3030)
9.2 Japan Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2015-2020)
9.3 Japan Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2015-2020)
10 Southeast Asia Pulmonary Drug Delivery Devices/Systems Market Facts & Figures
10.1 Southeast Asia Pulmonary Drug Delivery Devices/Systems Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2015-2020)
11 India Pulmonary Drug Delivery Devices/Systems Market Facts & Figures
11.1 India Pulmonary Drug Delivery Devices/Systems Sales Market Share by Company (2015-2020)
11.2 India Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2015-2020)
11.3 India Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Pulmonary Drug Delivery Devices/Systems Business
12.1 Hovione
12.1.1 Hovione Corporation Information
12.1.2 Hovione Business Overview
12.1.3 Hovione Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Hovione Pulmonary Drug Delivery Devices/Systems Products Offered
12.1.5 Hovione Recent Development
12.2 3M Health Care
12.2.1 3M Health Care Corporation Information
12.2.2 3M Health Care Business Overview
12.2.3 3M Health Care Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Gross Margin (2015-2020)
12.2.4 3M Health Care Pulmonary Drug Delivery Devices/Systems Products Offered
12.2.5 3M Health Care Recent Development
12.3 Bespak
12.3.1 Bespak Corporation Information
12.3.2 Bespak Business Overview
12.3.3 Bespak Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bespak Pulmonary Drug Delivery Devices/Systems Products Offered
12.3.5 Bespak Recent Development
12.4 BeyonDevices
12.4.1 BeyonDevices Corporation Information
12.4.2 BeyonDevices Business Overview
12.4.3 BeyonDevices Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Gross Margin (2015-2020)
12.4.4 BeyonDevices Pulmonary Drug Delivery Devices/Systems Products Offered
12.4.5 BeyonDevices Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Corporation Information
12.5.2 GlaxoSmithKline Business Overview
12.5.3 GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Gross Margin (2015-2020)
12.5.4 GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Products Offered
12.5.5 GlaxoSmithKline Recent Development
12.6 H&T Presspart
12.6.1 H&T Presspart Corporation Information
12.6.2 H&T Presspart Business Overview
12.6.3 H&T Presspart Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Gross Margin (2015-2020)
12.6.4 H&T Presspart Pulmonary Drug Delivery Devices/Systems Products Offered
12.6.5 H&T Presspart Recent Development
12.7 PARI Respiratory Equipment
12.7.1 PARI Respiratory Equipment Corporation Information
12.7.2 PARI Respiratory Equipment Business Overview
12.7.3 PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Gross Margin (2015-2020)
12.7.4 PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Products Offered
12.7.5 PARI Respiratory Equipment Recent Development
12.8 Philips Respironics
12.8.1 Philips Respironics Corporation Information
12.8.2 Philips Respironics Business Overview
12.8.3 Philips Respironics Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Philips Respironics Pulmonary Drug Delivery Devices/Systems Products Offered
12.8.5 Philips Respironics Recent Development
12.9 SHL
12.9.1 SHL Corporation Information
12.9.2 SHL Business Overview
12.9.3 SHL Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Gross Margin (2015-2020)
12.9.4 SHL Pulmonary Drug Delivery Devices/Systems Products Offered
12.9.5 SHL Recent Development
13 Pulmonary Drug Delivery Devices/Systems Manufacturing Cost Analysis
13.1 Pulmonary Drug Delivery Devices/Systems Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pulmonary Drug Delivery Devices/Systems
13.4 Pulmonary Drug Delivery Devices/Systems Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pulmonary Drug Delivery Devices/Systems Distributors List
14.3 Pulmonary Drug Delivery Devices/Systems Customers
15 Market Dynamics
15.1 Pulmonary Drug Delivery Devices/Systems Market Trends
15.2 Pulmonary Drug Delivery Devices/Systems Opportunities and Drivers
15.3 Pulmonary Drug Delivery Devices/Systems Market Challenges
15.4 Pulmonary Drug Delivery Devices/Systems Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Pulmonary Drug Delivery Devices/Systems Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Pulmonary Drug Delivery Devices/Systems Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Pulmonary Drug Delivery Devices/Systems Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Pulmonary Drug Delivery Devices/Systems Sales (K Units) by Region (2015-2020)
Table 5. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Region (2015-2020)
Table 6. Global Pulmonary Drug Delivery Devices/Systems Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Pulmonary Drug Delivery Devices/Systems Revenue Share by Region (2015-2020)
Table 8. Global Pulmonary Drug Delivery Devices/Systems Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Pulmonary Drug Delivery Devices/Systems Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Pulmonary Drug Delivery Devices/Systems Revenue Share Forecast by Region (2021-2026)
Table 12. Global Pulmonary Drug Delivery Devices/Systems (K Units) of Key Companies (2015-2020)
Table 13. Global Pulmonary Drug Delivery Devices/Systems Sales Share by Company (2015-2020)
Table 14. Global Pulmonary Drug Delivery Devices/Systems Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Pulmonary Drug Delivery Devices/Systems Revenue Share by Company (2015-2020)
Table 16. Global Pulmonary Drug Delivery Devices/Systems by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary Drug Delivery Devices/Systems as of 2019)
Table 17. Global Pulmonary Drug Delivery Devices/Systems Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Pulmonary Drug Delivery Devices/Systems Manufacturing Sites and Area Served
Table 19. Manufacturers Pulmonary Drug Delivery Devices/Systems Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Pulmonary Drug Delivery Devices/Systems Players
Table 22. Global Pulmonary Drug Delivery Devices/Systems Sales (K Units) by Type (2015-2020)
Table 23. Global Pulmonary Drug Delivery Devices/Systems Sales Share by Type (2015-2020)
Table 24. Global Pulmonary Drug Delivery Devices/Systems Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Pulmonary Drug Delivery Devices/Systems Price (K Units) by Type (2015-2020)
Table 26. Global Pulmonary Drug Delivery Devices/Systems Sales Share by Type (2021-2026)
Table 27. Global Pulmonary Drug Delivery Devices/Systems Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Pulmonary Drug Delivery Devices/Systems Revenue Share by Type (2021-2026)
Table 29. Global Pulmonary Drug Delivery Devices/Systems Price (K Units) by Type (2021-2026)
Table 30. Global Pulmonary Drug Delivery Devices/Systems Sales (K Units) by Application (2015-2020)
Table 31. Global Pulmonary Drug Delivery Devices/Systems Sales Share by Application (2015-2020)
Table 32. Global Pulmonary Drug Delivery Devices/Systems Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Pulmonary Drug Delivery Devices/Systems Price (K Units) by Application (2015-2020)
Table 34. Global Pulmonary Drug Delivery Devices/Systems Sales (K Units) by Application (2021-2026)
Table 35. Global Pulmonary Drug Delivery Devices/Systems Sales Share by Application (2021-2026)
Table 36. Global Pulmonary Drug Delivery Devices/Systems Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Pulmonary Drug Delivery Devices/Systems Revenue Share by Application (2021-2026)
Table 38. Global Pulmonary Drug Delivery Devices/Systems Price (K Units) by Application (2021-2026)
Table 39. United States Pulmonary Drug Delivery Devices/Systems Sales (K Units) by Company (2015-2020)
Table 40. United States Pulmonary Drug Delivery Devices/Systems Sales Market Share by Company (2015-2020)
Table 41. United States Pulmonary Drug Delivery Devices/Systems Sales (K Units) by Type (2015-2020)
Table 42. United States Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2015-2020)
Table 43. United States Pulmonary Drug Delivery Devices/Systems Sales (K Units) by Application (2015-2020)
Table 44. United States Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2015-2020)
Table 45. Europe Pulmonary Drug Delivery Devices/Systems Sales (K Units) by Company (2015-2020)
Table 46. Europe Pulmonary Drug Delivery Devices/Systems Sales Market Share by Company (2015-2020)
Table 47. Europe Pulmonary Drug Delivery Devices/Systems Sales (K Units) by Type (2015-2020)
Table 48. Europe Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2015-2020)
Table 49. Europe Pulmonary Drug Delivery Devices/Systems Sales (K Units) by Application (2015-2020)
Table 50. Europe Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2015-2020)
Table 51. China Pulmonary Drug Delivery Devices/Systems Sales (K Units) by Company (2015-2020)
Table 52. China Pulmonary Drug Delivery Devices/Systems Sales Market Share by Company (2015-2020)
Table 53. China Pulmonary Drug Delivery Devices/Systems Sales (K Units) by Type (2015-2020)
Table 54. China Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2015-2020)
Table 55. China Pulmonary Drug Delivery Devices/Systems Sales (K Units) by Application (2015-2020)
Table 56. China Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2015-2020)
Table 57. Japan Pulmonary Drug Delivery Devices/Systems Sales (K Units) by Company (2015-2020)
Table 58. Japan Pulmonary Drug Delivery Devices/Systems Sales Market Share by Company (2015-2020)
Table 59. Japan Pulmonary Drug Delivery Devices/Systems Sales (K Units) by Type (2015-2020)
Table 60. Japan Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2015-2020)
Table 61. Japan Pulmonary Drug Delivery Devices/Systems Sales (K Units) by Application (2015-2020)
Table 62. Japan Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Pulmonary Drug Delivery Devices/Systems Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Pulmonary Drug Delivery Devices/Systems Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Pulmonary Drug Delivery Devices/Systems Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Pulmonary Drug Delivery Devices/Systems Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2015-2020)
Table 69. India Pulmonary Drug Delivery Devices/Systems Sales (K Units) by Company (2015-2020)
Table 70. India Pulmonary Drug Delivery Devices/Systems Sales Market Share by Company (2015-2020)
Table 71. India Pulmonary Drug Delivery Devices/Systems Sales (K Units) by Type (2015-2020)
Table 72. India Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2015-2020)
Table 73. India Pulmonary Drug Delivery Devices/Systems Sales (K Units) by Application (2015-2020)
Table 74. India Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2015-2020)
Table 75. Hovione Corporation Information
Table 76. Hovione Description and Business Overview
Table 77. Hovione Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Hovione Pulmonary Drug Delivery Devices/Systems Product
Table 79. Hovione Recent Development
Table 80. 3M Health Care Corporation Information
Table 81. 3M Health Care Description and Business Overview
Table 82. 3M Health Care Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. 3M Health Care Pulmonary Drug Delivery Devices/Systems Product
Table 84. 3M Health Care Recent Development
Table 85. Bespak Corporation Information
Table 86. Bespak Description and Business Overview
Table 87. Bespak Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Bespak Pulmonary Drug Delivery Devices/Systems Product
Table 89. Bespak Recent Development
Table 90. BeyonDevices Corporation Information
Table 91. BeyonDevices Description and Business Overview
Table 92. BeyonDevices Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. BeyonDevices Pulmonary Drug Delivery Devices/Systems Product
Table 94. BeyonDevices Recent Development
Table 95. GlaxoSmithKline Corporation Information
Table 96. GlaxoSmithKline Description and Business Overview
Table 97. GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Product
Table 99. GlaxoSmithKline Recent Development
Table 100. H&T Presspart Corporation Information
Table 101. H&T Presspart Description and Business Overview
Table 102. H&T Presspart Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. H&T Presspart Pulmonary Drug Delivery Devices/Systems Product
Table 104. H&T Presspart Recent Development
Table 105. PARI Respiratory Equipment Corporation Information
Table 106. PARI Respiratory Equipment Description and Business Overview
Table 107. PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Product
Table 109. PARI Respiratory Equipment Recent Development
Table 110. Philips Respironics Corporation Information
Table 111. Philips Respironics Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Philips Respironics Description and Business Overview
Table 113. Philips Respironics Pulmonary Drug Delivery Devices/Systems Product
Table 114. Philips Respironics Recent Development
Table 115. SHL Corporation Information
Table 116. SHL Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. SHL Description and Business Overview
Table 118. SHL Pulmonary Drug Delivery Devices/Systems Product
Table 119. SHL Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Pulmonary Drug Delivery Devices/Systems Distributors List
Table 123. Pulmonary Drug Delivery Devices/Systems Customers List
Table 124. Pulmonary Drug Delivery Devices/Systems Market Key Trends
Table 125. Pulmonary Drug Delivery Devices/Systems Key Opportunities and Drivers
Table 126. Pulmonary Drug Delivery Devices/Systems Market Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Pulmonary Drug Delivery Devices/Systems Product Picture
Figure 2. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Pulmonary Drug Delivery Devices/Systems Market Share by Application in 2020 & 2026
Figure 6. Hospitals and Clinics Examples
Figure 7. Homecare Examples
Figure 8. Global Pulmonary Drug Delivery Devices/Systems Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Pulmonary Drug Delivery Devices/Systems Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Pulmonary Drug Delivery Devices/Systems Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Pulmonary Drug Delivery Devices/Systems Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Pulmonary Drug Delivery Devices/Systems Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Pulmonary Drug Delivery Devices/Systems Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Pulmonary Drug Delivery Devices/Systems Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Pulmonary Drug Delivery Devices/Systems Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Pulmonary Drug Delivery Devices/Systems Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Pulmonary Drug Delivery Devices/Systems Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Pulmonary Drug Delivery Devices/Systems Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Pulmonary Drug Delivery Devices/Systems Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Pulmonary Drug Delivery Devices/Systems Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Pulmonary Drug Delivery Devices/Systems Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Pulmonary Drug Delivery Devices/Systems Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Pulmonary Drug Delivery Devices/Systems Players Market Share by Revenue in Pulmonary Drug Delivery Devices/Systems 2015 & 2019
Figure 26. Pulmonary Drug Delivery Devices/Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Pulmonary Drug Delivery Devices/Systems Revenue Share by Type (2015-2020)
Figure 28. Global Pulmonary Drug Delivery Devices/Systems Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Pulmonary Drug Delivery Devices/Systems Revenue Share by Application (2015-2020)
Figure 30. Global Pulmonary Drug Delivery Devices/Systems Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type in 2019
Figure 32. United States Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type in 2019
Figure 33. Europe Pulmonary Drug Delivery Devices/Systems Sales Market Share by Company in 2019
Figure 34. Europe Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type in 2019
Figure 35. Europe Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application in 2019
Figure 36. China Pulmonary Drug Delivery Devices/Systems Sales Market Share by Company in 2019
Figure 37. China Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type in 2019
Figure 38. China Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application in 2019
Figure 39. Japan Pulmonary Drug Delivery Devices/Systems Sales Market Share by Company in 2019
Figure 40. Japan Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type in 2019
Figure 41. Japan Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application in 2019
Figure 42. Southeast Asia Pulmonary Drug Delivery Devices/Systems Sales Market Share by Company in 2019
Figure 43. Southeast Asia Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type in 2019
Figure 44. Southeast Asia Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application in 2019
Figure 45. India Pulmonary Drug Delivery Devices/Systems Sales Market Share by Company in 2019
Figure 46. India Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type in 2019
Figure 47. India Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Pulmonary Drug Delivery Devices/Systems
Figure 50. Manufacturing Process Analysis of Pulmonary Drug Delivery Devices/Systems
Figure 51. Pulmonary Drug Delivery Devices/Systems Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
肺用ドラッグデリバリーシステムの世界市場レポート2020 Pulmonary drug delivery systems are used to the treatment of various respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD), delivering locally acting drugs directly to their site of action. Advantages of pulmonary drug delivery systems over oral drugs is the excellent cap…- 注射・注入ベースドラッグデリバリーデバイスの世界市場レポート2020 Market Analysis and Insights: Global Injection And Infusion-based Drug Delivery Devices Market The global Injection And Infusion-based Drug Delivery Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Injection And …
- 埋め込み型ドラッグデリバリー装置の世界市場レポート2020 Implantable drug delivery devices are an alternative system that can achieve effective delivery with lower drug concentrations, and as a result, minimise side-effects whilst increasing patient compliance. BD, B.Braun, AngioDynamics, Smiths Medical and Teleflex, etc. are the leading products in the i…
- 薬物・遺伝子送達デバイスの世界市場レポート2020 Drug And Gene Delivery Devices provides a new treatment method, become the main treatment of the global market. The global market is being driven by the introduction of auto-injectors, adoption of advanced implants, and development of advanced devices that have revolutionized drug and gene delivery.…
- バッカル錠ドラッグデリバリーシステムの世界市場レポート2020 Market Analysis and Insights: Global Buccal Drug Delivery Systems Market The global Buccal Drug Delivery Systems market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Buccal Drug Delivery Systems Scope and Market Size The glo…